Inflammatix is a molecular diagnostics company with a mission to develop rapid tests that read the immune system to resolve major clinical and public health challenges. Their innovative approach to diagnostics involves creating host-response diagnostics that provide better patient care by understanding the cause and severity of infections. By analyzing a patient's immune system, they can help clinicians treat patients appropriately within minutes.

Inflammatix is dedicated to precision medicine on demand and aims to address the critical unmet need for quickly and accurately characterizing infections in acutely ill patients. Their pipeline includes tests for acute bacterial infections, viral infections, sepsis, autoimmune diseases, tropical infections, transplant rejection, and more. Their team of experts, including licensed physicians and data scientists, are at the forefront of groundbreaking science, utilizing machine learning and bioinformatics to develop these innovative diagnostic tools.

With their focus on better patient care and cutting-edge technology, Inflammatix is revolutionizing the field of diagnostics